TruCore Pathology is a team of board-certified, expert pathologists. They use Lumea’s proprietary tissue-handling technology to get larger, higher-quality samples that increase cancer detection. Lumea is advancing pathology into the…
Matthew Leavitt, MD, just co-founded the DDx Foundation. He aims to progress prostate cancer research and treatment through digital diagnostics. The other founders are pathologists E. David Crawford, MD, and…
Matthew Leavitt, MD, Lumea Founder, had the opportunity to speak at Cambridge Health Institute’s 7th annual Digital Pathology Conference. This Cambridge conference focused on transforming medicine in a digital world. “Seven…
PathNet uses Lumea digital pathology tech in its practices. PathNet is a coalition of independent pathology groups founded for pathologists by pathologists. Their united goal is to leverage Lumea’s digital…
Related posts: The Lumea BxChip® Saves Labs Time, Money, and Improves Quality Lumea Selects Tempus to Advance AI-Driven Digital Pathology Solutions Lumea Partners with P4 Diagnostix® in First Integrated LIS…
Learn how labs are using the Lumea BxChip® to save lab time, increase efficiency, reduce costs, and improve quality for potentially better diagnostic accuracy. Two recent articles praise the BxChip…
Abstract Objectives Current protocols for processing multiple prostate biopsy cores per case are uneconomical and cumbersome. Tissue fragmentation and loss compromise cancer diagnosis. We sought to study an alternate method…
Dr. Ashley Ross is a nationally recognized expert in prostate cancer. He previously worked as the head of the Urology Prostate Cancer Program at Johns Hopkins. He was also an…
Related posts: Pathologists’ Assistant Goes From Hating to Loving Prostate Biopsies Prostate BxChip® Saves Lab $75 per Patient and Reduces Pathologist time by 50% Lumea BxChip® Increased Both Tissue Yield and…
Abstract Introduction and Objectives Due to significant cuts in reimbursement, more efficient histology techniques are needed to maintain the economic viability of the histology laboratory. There is also an increasing…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
